Winner Medical Co (300888) Fair Value & Analysis
Healthcare · CN · Market cap 16.1B CNY
Fair value as of: Jun 24, 2026
Analysis
Winner Medical Co (300888) currently trades at ¥27.54, while our model-based Fair Value estimate is ¥29.01 — implying the stock looks roughly 5.3% undervalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Winner Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable medical products in China and internationally. It operates in two segments, Medical Consumables and Consumer Products. The company offers wound care solutions, including gauzes, bandages, adhesive and film dressings, cotton and non-woven products, basic kits, liquid skin protectants, debridement and exudate management products, anti-adhesion wound care, scar repair products, antimicrobial solutions, and biological active and compression treatment products; and operating room solutions, such as masks, gloves, protective apparel, surgical gowns and drapes, speciality drapes and packs, operating room solution accessories, general surgical kits and trays, and surgical consumables for pets. It also provides home care solutions comprising wound care products, which includes adhesive and silicone bandages, as well as first aid kits; and personal care products, …
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Winner Medical Co (300888) undervalued?
What is the fair value of 300888?
What is the quality score of 300888?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.